BWXT Reports Third Quarter 2018 Results
BWX Technologies, Inc. (NYSE: BWXT) reported third quarter 2018 revenue of $426 million, a 1.5% increase compared to $419 million in the third quarter of 2017.
BWXT to Present at Baird’s Global Industrial Conference
BWX Technologies, Inc. (NYSE:BWXT) President and Chief Executive Officer Rex D. Geveden will be presenting at the 2018 Baird’s Global Industrial Conference in Chicago at 2:30 p.m. CST on Nov. 7, 2018.
BWXT Joint Venture Awarded $850 Million Contract Extension at Portsmouth Gaseous Diffusion Plant
BWX Technologies, Inc. (NYSE:BWXT) announced today that the U.S. Department of Energy has awarded Fluor-BWXT Portsmouth, LLC a 30-month contract extension valued at approximately $850 million.
BWXT Subsidiary Awarded Six-Year, $505 Million Contract for Highly Enriched Uranium Downblending Services
BWX Technologies, Inc. announced today that its Nuclear Fuel Services, Inc. subsidiary was awarded a contract valued at $505 million for the downblending of 20.2 metric tons of highly enriched uranium to produce low enriched uranium suitable for use as commercial nuclear reactor fuel and for national defense programs.
BWXT to Participate in Morgan Stanley 6th Annual Laguna Conference
BWX Technologies, Inc. (NYSE:BWXT) announced today that Senior Vice President and Chief Financial Officer David Black will be making a presentation at the Morgan Stanley 6th Annual Laguna Conference in Laguna Beach, Calif., on September 13, 2018.
BWXT to Participate in Seaport Global Energy and Industrials Conference
BWX Technologies, Inc. (NYSE:BWXT) announced today that Senior Vice President and Chief Financial Officer David Black will be participating in the Seaport Global Energy and Industrials Conference in Chicago on August 28, 2018.
BWXT Names Gerhard Burbach to Board of Directors
BWX Technologies, Inc. (NYSE:BWXT) announced today that Gerhard “Gary” F. Burbach has been appointed to its board of directors.
BWXT Completes Acquisition of Sotera Health’s Nordion Medical Isotope Business
BWX Technologies, Inc. announced today that it has completed the acquisition of Sotera Health’s Nordion medical isotope business.
BWXT Signs Medical Isotope Development Agreement with Bruce Power
(LYNCHBURG, Va. – July 12, 2018) – BWX Technologies, Inc. (NYSE:BWXT) announced today that a subsidiary has signed an agreement with Bruce Power that will enable the two companies to collaborate on the development and supply of medical isotopes.
